The Switzerland Eye Research Institute published a landmark case report using light exposure and nutraceuticals to treat retinal degeneration
LUGANO, Switzerland–(BUSINESS WIRE)–Dr. Roberto Pinelli, CEO of Switzerland Eye Research Institute, announced today the publication of a landmark article in Archives Italienes de Biology, one of the oldest neuroscience journals in the world. http://www.architalbiol.org/index.php/aib/article/view/159134
“The Neurobiology of Nutraceuticals Combined with Light Exposure Solved a Case of Age-Related Macular Degeneration, AMD; the drusen disappeared in six months after this treatment Lugano Protocol”- dr Pinelli said: “Thanks also to the collaboration with other institutions.”
The Department of Chemistry and Biochemistry and the College of Health and Human Services, San Diego State University, USA are represented by Dr. Represented by Violet Vakunseh Bumah.
She said: “I am delighted to be working with Dr. Pinelli to collaborate on this clinical advance in solving AMD with light and nutraceuticals.”
The Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa and IRCCS Neuromed Pozzili, Italy, were represented by Prof. Francesco Fornai.
He said: “Dr. Pinelli has asked me to help evaluate the scientific basis for this finding, and I am pleased to help him and Dr. To help and work with Bumah to move this project forward in the future.”
“Scientific innovation” – said Dr. Pinelli – “encompasses the neuroregeneration of cells through the combination of specific phytochemicals and photobiomodulation; The mitochondria respond by activating ATP production in the photoreceptors in AMD, and this combination of energies (light radiation and phytochemical property) aids in autophagy while preserving the integrity of the retinal tissue.
This paper opens a new door on the role of light and nutraceuticals in the neuroscience of the eye through the retina, a “stargate” to the nervous system and hopefully towards neurodegenerative pathologies.